Cite

HARVARD Citation

    Brempelis, K. et al. (2020). Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record